32 Results for "

dihydropyrimidine

" in MedChemExpress (MCE) Product Catalog:
Products (32)

32 Results for "dihydropyrimidine" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-124062
CAS No.: 1198221-21-4
Purity:  99.76%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

TAS-114 is an orally active dual dUTPase/dihydropyrimidine dehydrogenase (DPD) inhibitor, can improving the therapeutic efficacy of fluoropyrimidine .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-17469
CAS No.: 103766-25-2
Synonyms: Gimestat
Gimeracil, a component of an oral fluoropyrimidine derivative S-1, inhibits DNA DSB repair and is a potent inhibitor of DPYD (dihydropyrimidine dehydrogenase, DPD) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W012926
CAS No.: 504-07-4
Synonyms: 5,6-Dihydrouracil
Dihydrouracil (5,6-Dihydrouracil), a metabolite of Uracil, can be used as a marker for identification of dihydropyrimidine dehydrogenase (DPD)-deficient .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W010450
CAS No.: 65-71-4
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease Cancer

Thymine, one of the four bases of DNA, is a substrate for rat liver dihydropyrimidine dehydrogenase (DPD), with a Km value of 2.2 μM, Ki of 24 μM (using 5-FU as the DPD substrate), and a specific activity of 0.68 nmol/min/mg .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10533
CAS No.: 59989-18-3
Purity:  99.93%
Synonyms: 5-Ethynyluracil; GW776C85
Research Areas:  

Cancer

Eniluracil (5-Ethynyluracil) is an orally active dihydropyrimidine dehydrogenase (DPD) inhibitor. Eniluracil irreversibly inhibits DPD, increases the oral bioavailability of 5-fluorouracil to 100%, and facilitates the uniform absorption and toxicity of 5-fluorouracil. Eniluracil can be used in cancer research of combination with fluoropyrimidines (including 5-fluorouracil) . Eniluracil is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-138820
CAS No.: 1010820-68-4
Purity:  98.3%
Target:  

HSP

Research Areas:  

Neurological Disease

SW02 is a potent activator of ATPase activity of Hsp70, with an EC50 of 150 μM. SW02 leads to accumulation of both total tau and phosphorylated tau (pTau) .
loading...
    loading...
Cat. No.: HY-W454906
CAS No.: 2377643-37-1
Research Areas:  

Others

tDHU, acid is a type of dihydropyrimidine Cereblon ligand and a benzoic acid linker conjugate, which can be used in the development of PROTACs .
loading...
    loading...
Cat. No.: HY-W012926S1
CAS No.: 334473-41-5
Synonyms: 5,6-Dihydrouracil-d4
Dihydrouracil-d4 is the deuterium labeled Dihydrouracil . Dihydrouracil (HY-W012926), a metabolite of Uracil, can be used as a marker for identification of dihydropyrimidine dehydrogenase (DPD)-deficient .
loading...
    loading...
Cat. No.: HY-134160
CAS No.: 696-06-0
Purity:  99.90%
Synonyms: 5-DHFU; 5-Fluorodihydropyrimidine-2,4-dione; 5-Fluorodihydrouracil
Research Areas:  

Cancer

5,6-Dihydro-5-Fluorouracil (5-DHFU; 5-Fluorodihydropyrimidine-2,4-dione) is the active metabolite of the thymidylate synthase inhibitor prodrug 5-fluorouracil (HY-90006), which is formed from 5-fluorouracil by dihydropyrimidine dehydrogenase (DPD). 5,6-Dihydro-5-Fluorouracil is cytotoxic to HaCaT keratinocytes (IC50=13.5 μM). Intravenous administration of 5,6-Dihydro-5-Fluorouracil (90 mg/kg/wk) in combination with 5-fluorouracil and the DPD inhibitor eniluracil (HY-10533) slows tumor growth in a rat colon cancer model.
loading...
    loading...
Cat. No.: HY-W012926S
CAS No.: 360769-22-8
Synonyms: 5,6-Dihydrouracil-13C4,15N2
Dihydrouracil- 13C4, 15N2 is the 13C and 15N labeled Dihydrouracil . Dihydrouracil (5,6-Dihydrouracil), a metabolite of Uracil, can be used as a marker for identification of dihydropyrimidine dehydrogenase (DPD)-deficient .
loading...
    loading...
Cat. No.: HY-W001983
CAS No.: 696-07-1
Research Areas:  

Cancer

5-Iodouracil (Compound 4b) is an irreversible dihydropyrimidine dehydrogenase (DPD) inhibitor (IC50=0.22 μM). 5-Iodouracil is promising for research of DPD-overexpressing solid tumors like non-small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-132888
CAS No.: 2733617-81-5
Target:  

Others

Research Areas:  

Metabolic Disease

NCATS-SM4487 is a highly selective unique dihydropyrimidine inhibitor against GALK1, with an IC50 value of 0.05 μM.
loading...
    loading...
Cat. No.: HY-134160S
CAS No.: 1189492-99-6
Synonyms: 5-DHFU-13C,15N2; 5-Fluorodihydropyrimidine-2,4-dione-13C,15N2; 5-Fluorodihydrouracil-13C,15N2
5,6-Dihydro-5-Fluorouracil- 13C, 15N2 (5-DHFU- 13C, 15N2) is the 13C- and 15N-labeled labeled 5,6-Dihydro-5-Fluorouracil (HY-134160). 5,6-Dihydro-5-Fluorouracil (5-DHFU; 5-Fluorodihydropyrimidine-2,4-dione) is the active metabolite of the thymidylate synthase inhibitor prodrug 5-fluorouracil (HY-90006), which is formed from 5-fluorouracil by dihydropyrimidine dehydrogenase (DPD). 5,6-Dihydro-5-Fluorouracil is cytotoxic to HaCaT keratinocytes (IC50=13.5 μM). Intravenous administration of 5,6-Dihydro-5-Fluorouracil (90 mg/kg/wk) in combination with 5-fluorouracil and the DPD inhibitor eniluracil (HY-10533) slows tumor growth in a rat colon cancer model.
loading...
    loading...
Cat. No.: HY-W005294S
CAS No.: 1189485-35-5
Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate-d3 is the deuterium labeled Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxylate .
loading...
    loading...
Cat. No.: HY-W012926R
CAS No.: 504-07-4
Synonyms: 5,6-Dihydrouracil (Standard)
Dihydrouracil (Standard) is the analytical standard of Dihydrouracil. This product is intended for research and analytical applications. Dihydrouracil (5,6-Dihydrouracil), a metabolite of Uracil, can be used as a marker for identification of dihydropyrimidine dehydrogenase (DPD)-deficient[1][2].
loading...
    loading...
Cat. No.: HY-162623
Target:  

EGFR

Research Areas:  

Cancer

EGFR/HER2-IN-15, a dihydropyrimidine, is a potent EGFR/HER2 inhibitor. EGFR/HER2-IN-15 significantly inhibits EGFR wt activity with an IC50 of 37.21 nM. EGFR/HER2-IN-15 has anticaner effects .
loading...
    loading...
Cat. No.: HY-172621
CAS No.: 2055746-08-0
Target:  

EGFR

Research Areas:  

Cancer

EGFR-IN-159 (compound 12), a dihydropyrimidine, is a potent EGFR inhibitor with an IC50 value of 29.00 nM. EGFR-IN-159 exhibits dose-dependent inhibition against EGFR and HER2. EGFR-IN-159 shows cytotoxicity against MCF-7 breast cancer cells and Vero cells with IC50 values of 16.07 μg/mL and 35.98 μg/mL, respectively. EGFR-IN-159 has no BBB permeation. EGFR-IN-159 shows appreciable anti-cancer activity .
loading...
    loading...
Cat. No.: HY-162788
CAS No.: 418799-16-3
Target:  

EGFR

Research Areas:  

Cancer

EGFR-IN-121 (compound 15) is a EGFR and VEGFR-2 dual inhibitor with IC50s of 84 and 3.5 nM, respectively .
loading...
    loading...
Cat. No.: HY-17469R
CAS No.: 103766-25-2
Synonyms: Gimestat (Standard)
Gimeracil (Standard) is the analytical standard of Gimeracil. This product is intended for research and analytical applications. Gimeracil, a component of an oral fluoropyrimidine derivative S-1, inhibits DNA DSB repair and is a potent inhibitor of DPYD (dihydropyrimidine dehydrogenase, DPD) .
loading...
    loading...
Cat. No.: HY-W777340
CAS No.: 1184979-29-0
Synonyms: Gimestat-13C3
Gimeracil- 13C3 (Gimestat- 13C3) is the 13C-labeled Gimeracil (HY-17469). Gimeracil, a component of an oral fluoropyrimidine derivative S-1, inhibits DNA DSB repair and is a potent inhibitor of DPYD (dihydropyrimidine dehydrogenase, DPD) .
loading...
    loading...